InvestorsHub Logo
Followers 155
Posts 2641
Boards Moderated 0
Alias Born 01/29/2004

Re: dia76ca post# 398744

Tuesday, 01/17/2023 4:42:51 PM

Tuesday, January 17, 2023 4:42:51 PM

Post# of 462069
Get it right. Blarcamesine reduces chances of falling.

Interesting that those on placebo had a higher rate of falls than those on drug.
Yes, that is interesting, isn't it?

Check the data presented on page 25 here:
https://www.investorvillage.com/uploads/86653/files/CTAD_Slide_Deck.pdf

In the placebo arm of the study (161 people), a total of 16 were reported to have fallen during the study. That was 9.9% of the people in the placebo arm (who got no blarcamesine).

Over in the blarcamesine-treated arm of the study there were 301 people, of which 21 were reported as falling during the study. That's 7.0% of the participants.

The straight facts: 9.9% of the study participants not taking any blarcamesine had falls. Of those on the drug, only 7.0% fell. No other way to interpret this. Blarcamesine reduced the chances of falling.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News